Emergence of Nanomedicine as Cancer Targeted Magic Bullets: Recent Development and Need to Address the Toxicity Apprehension

Publisher： Bentham Science Publishers

E-ISSN： 1875-6220|9|4|319-329

ISSN： 1570-1638

Source： Current Drug Discovery Technologies, Vol.9, Iss.4, 2012-12, pp. : 319-329

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern

By  

Current Pharmaceutical Design, Vol. 17, Iss. 18, 2011-06 ,pp. : 1834-1850

Bentham Science Publishers

Access to resources Recommend Favorite

Magic Bullets aimed below the Belt: Monoclonal Antibodies for Prostate Cancer Therapy

By  

Pharmaceutical Innovation, Vol. 11, Iss. 4, 2002-06 ,pp. : 12-15

Adis International

Access to resources Recommend Favorite

VIP-targeted cytotoxic nanomedicine for breast cancer

By Dagar Aparna  

Drug Delivery and Translational Research, Vol. 2, Iss. 6, 2012-12 ,pp. : 454-462

Springer Publishing Company

Access to resources Recommend Favorite

The emergence of resistance to targeted cancer therapeutics

By Mellinghoff Ingo K   Sawyers Charles L  

Pharmacogenomics, Vol. 3, Iss. 5, 2002-09 ,pp. : 603-623

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomics of lung cancer: with a view to address EGFR-targeted therapies

By Joshi Victoria A   Kucherlapati Raju  

Pharmacogenomics, Vol. 8, Iss. 9, 2007-09 ,pp. : 1211-1220

Future Medicine

Access to resources Recommend Favorite